MOACM
IMCR icon

Mutual of America Capital Management’s Immunocore IMCR Stock Holding History

Mutual of America Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,063
Closed -$849K – 1468
2024
Q1 		$849K Sell
13,063
-691
-5% -$47.4K 0.01% 1064
2023
Q4 		$940K Buy
+13,754
New +$715K 0.01% 1051

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Mutual of America Capital Management's IMCR Position: Q2 2024 in Review

Mutual of America Capital Management sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 13,063 shares — an estimated $849K sold.

Mutual of America Capital Management first reported a position in IMCR in Q4 2023 and held it in 2 quarters. The position peaked at $940K in Q4 2023. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Mutual of America Capital Management reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Mutual of America Capital Management sold 13,063 Immunocore shares in Q2 2024, an estimated $849K.
  • Mutual of America Capital Management first reported a position in Immunocore in Q4 2023 and held it in 2 quarters.
  • Mutual of America Capital Management's Immunocore position peaked at $940K in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Mutual of America Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.